Search research articles
Contact Us
Filters
Showing results (221-230 of 257) with videos related to
Page
of 26
Sort By:
Diagnostic Microbiology and Infectious Disease
|
March 14, 2016
Antimicrobial activity of ceftaroline and comparator agents when tested against numerous species of coagulase-negative Staphylococcus causing infection in US hospitals
Helio S Sader, David J Farrell, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease
|
September 10, 2016
Telavancin activity tested against a collection of Staphylococcus aureus isolates causing pneumonia in hospitalized patients in the United States (2013-2014)
Leonard R Duncan, Jennifer I Smart, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease
|
April 10, 2022
Aztreonam in combination with imipenem-relebactam against clinical and isogenic strains of serine and metallo-β-lactamase-producing enterobacterales
Mark Biagi, Michelle Lee, Tiffany Wu, et al.
Antimicrobial Agents and Chemotherapy
|
December 12, 2007
Prevalence of and molecular basis for tuberculosis drug resistance in the Republic of Georgia: validation of a QIAplex system for detection of drug resistance-related mutations
Medea Gegia, Nino Mdivani, Rodrigo E Mendes, et al.
Jac-Antimicrobial Resistance
|
October 24, 2025
Antimicrobial susceptibility of Enterobacterales causing infection in the elderly: focus on aztreonam-avibactam and recently approved β-lactamase inhibitor combinations
Helio S Sader, Rodrigo E Mendes, John H Kimbrough, et al.
Jac-Antimicrobial Resistance
|
October 21, 2021
Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from respiratory samples of patients hospitalized with pneumonia in Western Europe, Eastern Europe and the USA: results from the SENTRY Antimicrobial Surveillance Program (2016-19)
Helio S Sader, Jennifer M Streit, Cecilia G Carvalhaes, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 2015
Noninvasive Streptococcus pneumoniae serotypes recovered from hospitalized adult patients in the United States in 2009 to 2012
Rodrigo E Mendes, Rosalind C Hollingsworth, Andrew Costello, et al.
Antimicrobial Agents and Chemotherapy
|
December 16, 2015
β-Lactamase Characterization of Gram-Negative Pathogens Recovered from Patients Enrolled in the Phase 2 Trials for Ceftazidime-Avibactam: Clinical Efficacies Analyzed against Subsets of Molecularly Characterized Isolates
Rodrigo E Mendes, Mariana Castanheira, Leanne Gasink, et al.
Diagnostic Microbiology and Infectious Disease
|
February 1, 2025
Surveillance of omadacycline against 35,000 bacterial clinical isolates from the United States (2019-2023)
Michael D Huband, Kelley A Fedler, Rodrigo E Mendes, et al.
The Journal of Antimicrobial Chemotherapy
|
April 17, 2018
ZAAPS programme results for 2016: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 42 countries
Rodrigo E Mendes, Lalitagauri Deshpande, Jennifer M Streit, et al.
Page
of 26
Search research articles
Search
Showing results (221-230 of 257) with videos related to
Sort By:
Page
of 26
Diagnostic Microbiology and Infectious Disease
|
March 14, 2016
Antimicrobial activity of ceftaroline and comparator agents when tested against numerous species of coagulase-negative Staphylococcus causing infection in US hospitals
Helio S Sader, David J Farrell, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease
|
September 10, 2016
Telavancin activity tested against a collection of Staphylococcus aureus isolates causing pneumonia in hospitalized patients in the United States (2013-2014)
Leonard R Duncan, Jennifer I Smart, Robert K Flamm, et al.
Diagnostic Microbiology and Infectious Disease
|
April 10, 2022
Aztreonam in combination with imipenem-relebactam against clinical and isogenic strains of serine and metallo-β-lactamase-producing enterobacterales
Mark Biagi, Michelle Lee, Tiffany Wu, et al.
Antimicrobial Agents and Chemotherapy
|
December 12, 2007
Prevalence of and molecular basis for tuberculosis drug resistance in the Republic of Georgia: validation of a QIAplex system for detection of drug resistance-related mutations
Medea Gegia, Nino Mdivani, Rodrigo E Mendes, et al.
Jac-Antimicrobial Resistance
|
October 24, 2025
Antimicrobial susceptibility of Enterobacterales causing infection in the elderly: focus on aztreonam-avibactam and recently approved β-lactamase inhibitor combinations
Helio S Sader, Rodrigo E Mendes, John H Kimbrough, et al.
Jac-Antimicrobial Resistance
|
October 21, 2021
Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from respiratory samples of patients hospitalized with pneumonia in Western Europe, Eastern Europe and the USA: results from the SENTRY Antimicrobial Surveillance Program (2016-19)
Helio S Sader, Jennifer M Streit, Cecilia G Carvalhaes, et al.
Antimicrobial Agents and Chemotherapy
|
July 1, 2015
Noninvasive Streptococcus pneumoniae serotypes recovered from hospitalized adult patients in the United States in 2009 to 2012
Rodrigo E Mendes, Rosalind C Hollingsworth, Andrew Costello, et al.
Antimicrobial Agents and Chemotherapy
|
December 16, 2015
β-Lactamase Characterization of Gram-Negative Pathogens Recovered from Patients Enrolled in the Phase 2 Trials for Ceftazidime-Avibactam: Clinical Efficacies Analyzed against Subsets of Molecularly Characterized Isolates
Rodrigo E Mendes, Mariana Castanheira, Leanne Gasink, et al.
Diagnostic Microbiology and Infectious Disease
|
February 1, 2025
Surveillance of omadacycline against 35,000 bacterial clinical isolates from the United States (2019-2023)
Michael D Huband, Kelley A Fedler, Rodrigo E Mendes, et al.
The Journal of Antimicrobial Chemotherapy
|
April 17, 2018
ZAAPS programme results for 2016: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 42 countries
Rodrigo E Mendes, Lalitagauri Deshpande, Jennifer M Streit, et al.
Page
of 26